Who
Gilbert H. Kliman
Director
Company insider
Files Form 4 as: Director, Glaukos; Director, STAAR Surgical; Director and 10% owner and Other, Doximity; 10% owner, Braze; 10% owner, PMV Pharmaceuticals; Director and 10% owner, Venus Concept; Director and 10% owner, Avedro; 10% owner, Eiger BioPharmaceuticals.
In numbers
- Trades disclosed
- 242
- Buys
- 6
- Sells
- 26
- Bought
- $6.4M
- Sold
- $299.5M
- Companies
- 13
- Companies where not an officer
- 13
- First trade
- 5 Jan 2006
- Last trade
- 19 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 20 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $64K2,500 at $25.77 | filing |
| 19 Aug 2026filed 20 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $475K2,500 at $190.00 | filing |
| 19 Aug 2026filed 20 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 19 Aug 2026filed 20 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 19 Aug 2026filed 20 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $64K2,500 at $25.77 | filing |
| 19 Aug 2026filed 20 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $475K2,500 at $190.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $123K5,000 at $24.69 | filing |
| 14 May 2026filed 18 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $704K5,000 at $140.76 | filing |
| 14 May 2026filed 18 May 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | $123K5,000 at $24.69 | filing |
| 14 May 2026filed 18 May 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | $123K5,000 at $24.69 | filing |
| 14 May 2026filed 18 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $123K5,000 at $24.69 | filing |
| 14 May 2026filed 18 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $704K5,000 at $140.76 | filing |
| 11 May 2026filed 13 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $123K5,000 at $24.69 | filing |
| 11 May 2026filed 13 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $675K5,000 at $135.00 | filing |
News
Glaukos Expands Retinal Pipeline With RevOpsis Deal - Orange County Business JournalGKOS · ocbj.com · 19 Oct 2026
0 headlines in the last 90 days name Gilbert H. Kliman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.